Medtronic plc — Director's Dealing 2019

Nov 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2019-11-01

Reporting Person: WHITE ROBERT JOHN (EVP & President MITG)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-01	Ordinary Shares	M	9643	$29.52	Acquired	61711	Direct
2019-11-01	Ordinary Shares	S	3762	$109.659	Disposed	57949	Direct
2019-11-01	Ordinary Shares	M	37209	$36.58	Acquired	95158	Direct
2019-11-01	Ordinary Shares	S	28428	$109.108	Disposed	66730	Direct
2019-11-01	Ordinary Shares	S	14662	$109.667	Disposed	52068	Direct
2019-11-01	Ordinary Shares	M	5313	$47.00	Acquired	57381	Direct
2019-11-01	Ordinary Shares	S	3349	$109.113	Disposed	54032	Direct
2019-11-01	Ordinary Shares	S	1964	$109.663	Disposed	52068	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-01	Stock Option (Right to Buy)	$29.52	M	9643	Disposed	2021-11-30	Ordinary Shares (9643)	Direct
2019-11-01	Stock Option (Right to Buy)	$36.58	M	37209	Disposed	2022-12-02	Ordinary Shares (37209)	Direct
2019-11-01	Stock Option (Right to Buy)	$47.00	M	5313	Disposed	2023-12-01	Ordinary Shares (5313)	Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2: This balance increased by 151 shares due to exempt transactions such as dividend reinvestment.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.46 to $109.98, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.44 to $109.44, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.45 to $110.18, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.46 to $109.43, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.46 to $110.01, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.